Junxiao Hu

432 total citations
32 papers, 170 citations indexed

About

Junxiao Hu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Junxiao Hu has authored 32 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Junxiao Hu's work include Cancer Immunotherapy and Biomarkers (8 papers), Renal cell carcinoma treatment (7 papers) and Genetic factors in colorectal cancer (4 papers). Junxiao Hu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Renal cell carcinoma treatment (7 papers) and Genetic factors in colorectal cancer (4 papers). Junxiao Hu collaborates with scholars based in United States, Canada and Belgium. Junxiao Hu's co-authors include Dexiang Gao, Swati Patel, David A. Lieberman, Thomas F. Imperiale, Jennifer M. Kolb, Kristen DeSanto, C. Richard Boland, Siddharth Singh, Aaron Clauset and Kian Behbakht and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Junxiao Hu

25 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junxiao Hu United States 7 91 64 54 29 28 32 170
Sook Kyung South Korea 8 104 1.1× 65 1.0× 105 1.9× 18 0.6× 35 1.3× 29 229
Nikola Hájková Czechia 9 69 0.8× 37 0.6× 79 1.5× 15 0.5× 14 0.5× 25 194
Andrej Lissat Germany 7 43 0.5× 55 0.9× 94 1.7× 31 1.1× 25 0.9× 17 181
Elie W. Akl United States 7 79 0.9× 98 1.5× 104 1.9× 19 0.7× 18 0.6× 12 230
Puchun Er China 8 68 0.7× 55 0.9× 96 1.8× 15 0.5× 24 0.9× 15 193
Hasan Mirza United Kingdom 8 97 1.1× 33 0.5× 93 1.7× 21 0.7× 15 0.5× 19 198
Amanda J. Loch Canada 4 89 1.0× 63 1.0× 135 2.5× 22 0.8× 15 0.5× 5 210
Monika Kowal Poland 9 53 0.6× 42 0.7× 141 2.6× 23 0.8× 31 1.1× 15 258
Shuqiong Fan China 7 88 1.0× 91 1.4× 102 1.9× 25 0.9× 14 0.5× 10 204
Jianli Zhao China 6 110 1.2× 44 0.7× 100 1.9× 24 0.8× 12 0.4× 19 252

Countries citing papers authored by Junxiao Hu

Since Specialization
Citations

This map shows the geographic impact of Junxiao Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxiao Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxiao Hu more than expected).

Fields of papers citing papers by Junxiao Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxiao Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxiao Hu. The network helps show where Junxiao Hu may publish in the future.

Co-authorship network of co-authors of Junxiao Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Junxiao Hu. A scholar is included among the top collaborators of Junxiao Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxiao Hu. Junxiao Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Corr, Bradley R., Ashley Haggerty, Sarah E. Taylor, et al.. (2025). A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer. Gynecologic Oncology. 200. 58–67.
3.
Robin, Tyler P., Junxiao Hu, Bernard L. Jones, et al.. (2025). Phase I trial of stereotactic body radiation therapy (SBRT) for limited site locoregional recurrences of ovarian cancer. Gynecologic Oncology. 200. 175–179.
4.
Wang, Yeping, Cheng Zheng, Junxiao Hu, et al.. (2025). Target inhibition of SPAK in choroid plexus attenuates T cell infiltration and demyelination in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 22(1). 80–80.
5.
Wolsky, Rebecca J., Christian Rickert, Kimberly R. Jordan, et al.. (2024). The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma. Cancer Immunology Research. 12(11). 1492–1507. 2 indexed citations
6.
Corr, Bradley R., Ashley Haggerty, Stefan Gysler, et al.. (2024). A phase II, randomized, double-blind study of the use of rucaparib versus placebo maintenance therapy in metastatic and recurrent endometrial cancer. Gynecologic Oncology. 190. S63–S63.
7.
8.
Johnson, Bryan, Meher P. Boorgula, Andrew Goodspeed, et al.. (2024). Abstract 1390: Pulmonary viral infection promotes the awakening of dormant metastatic breast cancer cells in lungs. Cancer Research. 84(6_Supplement). 1390–1390. 1 indexed citations
9.
Kessler, Elizabeth R., Eryn Callihan, Junxiao Hu, et al.. (2023). A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer Research Communications. 3(6). 1004–1012. 3 indexed citations
10.
Gilbert, Danielle, Junxiao Hu, Theresa Medina, Elizabeth R. Kessler, & Elaine T. Lam. (2023). Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors. Human Vaccines & Immunotherapeutics. 19(1). 2207438–2207438. 8 indexed citations
11.
Piper, Miles, Richard B. Ross, Junxiao Hu, et al.. (2023). Vasculitis, CA19-9, and Perineural Invasion Differentially Predict Response and Surgical Outcome in Pancreatic Ductal Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 116(3). 627–639. 4 indexed citations
12.
Sottnik, Joseph L., Sydney K. Robinson, Steffi Oesterreich, et al.. (2023). WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers. Cancer Research Communications. 4(1). 134–151. 4 indexed citations
13.
Hu, Junxiao, Katharine A. Collier, Rana R. McKay, et al.. (2023). Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study. Clinical Genitourinary Cancer. 21(4). 483–490. 7 indexed citations
14.
Hu, Junxiao, et al.. (2023). Bone health practices in metastatic prostate cancer (mPCA).. Journal of Clinical Oncology. 41(16_suppl). e17119–e17119.
15.
Kolb, Jennifer M., Junxiao Hu, Kristen DeSanto, et al.. (2021). Early-Age Onset Colorectal Neoplasia in Average-Risk Individuals Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis. Gastroenterology. 161(4). 1145–1155.e12. 35 indexed citations
16.
Lentz, Robert W., Junxiao Hu, Alexis D. Leal, et al.. (2021). Tissue tumor mutational burden (TMB) as a biomarker of efficacy with immune checkpoint inhibitors (ICI) in metastatic gastrointestinal (mGI) cancers.. Journal of Clinical Oncology. 39(15_suppl). e14559–e14559. 2 indexed citations
17.
Jordan, Kimberly R., Matthew J. Sikora, Jill E. Slansky, et al.. (2020). The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval. Clinical Cancer Research. 26(23). 6362–6373. 40 indexed citations
18.
Goldstein, Nathaniel B., Andrea Steel, Maranke I. Koster, et al.. (2020). Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling. Journal of Investigative Dermatology. 141(3). 638–647.e13. 15 indexed citations
19.
Borges, Virginia F., et al.. (2020). Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer. npj Breast Cancer. 6(1). 56–56. 6 indexed citations
20.
Patel, Swati, Dennis J. Ahnen, Junxiao Hu, et al.. (2020). Poor Knowledge of Personal and Familial Colorectal Cancer Risk and Screening Recommendations Associated with Advanced Colorectal Polyps. Digestive Diseases and Sciences. 65(9). 2542–2550. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sook Kyung Breakdown of academic impact, for papers by Nikola Hájková Breakdown of academic impact, for papers by Andrej Lissat Breakdown of academic impact, for papers by Elie W. Akl Breakdown of academic impact, for papers by Puchun Er Breakdown of academic impact, for papers by Hasan Mirza Breakdown of academic impact, for papers by Amanda J. Loch Breakdown of academic impact, for papers by Monika Kowal Breakdown of academic impact, for papers by Shuqiong Fan Breakdown of academic impact, for papers by Jianli Zhao
Rankless by CCL
2026